Standard Operating Procedure for Management of CMC Changes After Approval
| Department | Regulatory Affairs |
| SOP No. | RA/2026/672 |
| Supersedes | NA |
| Page No. | 1 of X |
| Issue Date | 11/04/2026 |
| Effective Date | 11/04/2026 |
| Review Date | 11/04/2028 |
Purpose
This Standard Operating Procedure (SOP) establishes a systematic approach for the management and control of Chemistry, Manufacturing, and Controls (CMC) changes after regulatory approval. It aims to ensure all post-approval changes are documented, evaluated, authorized, and communicated appropriately, thereby maintaining compliance with applicable regulatory requirements and ensuring consistent product quality and safety throughout the product lifecycle.
Scope
This SOP applies to all CMC-related changes that occur after initial regulatory approval including but not limited to formulation, manufacturing process, equipment, analytical methods, specifications, packaging materials, and storage conditions. It encompasses all departments involved in submitting, reviewing, approving, and implementing post-approval changes for pharmaceutical products across all dosage forms and manufacturing sites. Exclusions include non-CMC related variations and changes that are managed under separate procedural documents.
Responsibilities
The following roles hold responsibilities within this SOP:
- Regulatory Affairs Team: Initiate, assess, compile, and submit CMC change documentation to regulatory authorities.
- Quality Assurance: Review and verify that changes comply with GMP and quality standards.
- Manufacturing/Production: Provide technical inputs and implement approved changes in the manufacturing process.
- Quality Control: Conduct testing and validation related to changes as required.
- Validation/Engineering: Support qualification and validation activities arising from the change.
- Document Control: Manage version control and archiving of change documentation and records.
Accountability
The Head of Regulatory Affairs is accountable for the overall implementation, periodic review, monitoring compliance, and effectiveness of this SOP. They will ensure that all post-approval CMC changes are managed in accordance with regulatory expectations and internal quality systems, and oversee escalation of deviations or non-compliances.
Procedure
1. Initiation and Identification: Upon recognition of a need for a CMC change post-approval, the proposed change shall be formally documented through a Change Request form detailing the nature, rationale, and potential impacts of the change.
2. Change Impact Assessment: Conduct a comprehensive risk and impact assessment including evaluation of potential effects on product quality, safety, efficacy, GMP compliance, and regulatory status. Involve cross-functional teams to provide inputs specific to manufacturing, quality control, validation, and supply chain.
3. Classification and Regulatory Strategy: Based on the impact assessment, classify the change according to regulatory guidance (e.g., Major, Moderate, Minor) to determine the submission requirements.
4. Documentation Preparation: Prepare change package including revised batch records, validation protocols/reports, analytical methods, stability data, and updated specifications as applicable. Document changes must be controlled and versioned correctly.
5. Internal Review and Approval: Circulate the change package for formal review and approval by Quality Assurance, Regulatory Affairs, and other relevant departments. Approval is contingent upon compliance with internal quality standards and readiness for submission or implementation.
6. Regulatory Submission: Compile regulatory submission dossiers as per country-specific requirements outlining the proposed changes, supporting data, and justification. Submit dossiers to pertinent regulatory agencies within stipulated timelines.
7. Implementation: Upon regulatory approval or acceptance of the change (if applicable), implement the change in controlled environments following updated SOPs, validated methods, and documented procedures.
8. Verification and Monitoring: Conduct monitoring and verification activities such as in-process controls, post-change validation, and stability studies to confirm change acceptance criteria are met.
9. Deviation Management: Any deviations or unexpected outcomes during implementation shall be documented, investigated, and managed per deviation management procedures.
10. Documentation and Record Keeping: Maintain complete, accurate, and secure records of all change-related documents, approvals, communications, and regulatory correspondences in compliance with document control and retention policies.
11. Review and Continuous Improvement: Periodically review post-approval change controls for effectiveness and update this SOP as necessary to incorporate lessons learned, regulatory changes, or process improvements.
Abbreviations
CMC: Chemistry, Manufacturing, and Controls
GMP: Good Manufacturing Practice
SOP: Standard Operating Procedure
QA: Quality Assurance
QC: Quality Control
RA: Regulatory Affairs
Documents
- Post-Approval Change Request Form (Annexure-1)
- CMC Change Impact Assessment Report (Annexure-2)
- Regulatory Submission Dossier Template (Annexure-3)
References
ICH Q12—Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management
FDA Guidance for Industry: Postapproval Manufacturing Changes to be Documented in Annual Reports
EMA Guideline on the Chemistry, Manufacturing and Control (CMC) Changes
Internal Quality Management System Policies and Procedures
Applicable Pharmacopoeial Standards
Version
1.0
Approval
| Prepared By | |
| Checked By | |
| Approved By |
Annexures
Annexure-1: Post-Approval Change Request Form
Purpose: To formally document the initiation and details of a proposed CMC change after product approval.
| Change Request No. | CRC-2026-015 |
| Date of Request | 05/04/2026 |
| Department Raising Request | Manufacturing |
| Product Name | Product X |
| Description of Change | Modification of granulation process parameters |
| Reason for Change | To improve batch consistency and reduce variability |
| Impact on Quality/Safety | Expected to enhance product uniformity without affecting stability |
| Proposed Implementation Date | 15/06/2026 |
| Raised By | Manufacturing Unit |
| Prepared By | |
| Reviewed By | |
| Approved By |
Annexure-2: CMC Change Impact Assessment Report
Purpose: To assess and document the risk and impact of the proposed post-approval CMC change on product quality and regulatory compliance.
| Assessment Report No. | IA-2026-089 |
| Date of Assessment | 10/04/2026 |
| Change Reference | CRC-2026-015 |
| Impact on Manufacturing Process | Process parameters adjusted to optimize granulation |
| Impact on Stability | No anticipated negative effect; ongoing stability studies planned |
| Impact on Specifications | None; existing specifications remain valid |
| Risk Level | Moderate |
| Recommended Regulatory Action | Prior approval submission |
| Reviewed By | |
| Approved By |
Annexure-3: Regulatory Submission Dossier Template
Purpose: Template to compile all necessary data and documents for submission of CMC changes to regulatory authorities.
| Submission ID | SUB-RA-2026-004 |
| Submission Date | 20/04/2026 |
| Product Name | Product X |
| Change Description | Adjustment of granulation process parameters to improve quality consistency |
| Supporting Documents Included |
|
| Submitted By | Regulatory Affairs |
| Checked By | |
| Approved By |
Revision History
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
| 11/04/2026 | 1.0 | Initial issue | New SOP creation |